You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Lung Cancer, Lung Cancer Trial (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))

Not yet recruiting
  • Recurrent Lung Cancer
  • Lung Cancer
  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
  • (no location specified)
Nov 21, 2022

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Brachytherapy, NSCLC Trial in Beijing (3D-printing Template-assisted CT-guided I-125 Seeds Implantation)

Recruiting
  • Brachytherapy
  • Non-small Cell Lung Cancer
  • 3D-printing Template-assisted CT-guided I-125 Seeds Implantation
  • Beijing, Beijing, China
    Peking University Third Hospital
May 31, 2022

Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

Recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
Jun 27, 2022

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 23, 2023

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • (no location specified)
Jan 9, 2023

Cancer, Non Small Cell Lung Cancer Trial in Salt Lake City (PET Imaging, Erlotinib, Bevacizumab)

Completed
  • Cancer
  • Non Small Cell Lung Cancer
  • PET Imaging
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Dec 16, 2021

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Adenosine A2B Receptor Antagonist PBF-1129
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 1, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)

Not yet recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Hangzhou, China
  • +2 more
Feb 5, 2023

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Apr 21, 2023

    Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

    Recruiting
    • Extensive-stage Small Cell Lung Cancer
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 27, 2023

    Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

    Recruiting
    • Metastatic Non-Small Lung Cell Cancer
    • +4 more
    • Atlanta, Georgia
      Winship Cancer Institute of Emory University
    Oct 19, 2022

    Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

    Not yet recruiting
    • Sinonasal Cancer
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 5, 2023

    Lung Cancer, SCLC Trial in United States (Nivolumab, Plinabulin, Ipilimumab)

    Recruiting
    • Lung Cancer
    • SCLC
    • Duarte, California
    • +7 more
    Jan 18, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

    Recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • +3 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 10, 2022

    Non Small Cell Lung Cancer Recurrent Trial (Toripalimab, Anlotinib and Chemotherapy)

    Not yet recruiting
    • Non Small Cell Lung Cancer Recurrent
    • Toripalimab, Anlotinib and Chemotherapy
    • (no location specified)
    Apr 24, 2023

    Recurrent Lung Squamous Cell Carcinoma, Stage IV Lung Squamous Cell Carcinoma AJCC v7 Trial in United States (Laboratory

    Completed
    Has Results
    • Recurrent Lung Squamous Cell Carcinoma
    • Stage IV Lung Squamous Cell Carcinoma AJCC v7
    • Laboratory Biomarker Analysis
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Mar 16, 2022

    Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

    Recruiting
    • Triple Negative Breast Cancer
    • +14 more
    • LYL797
    • Scottsdale, Arizona
    • +10 more
    Jan 30, 2023